Literature DB >> 13038888

Pyrazinamide (aldinamide*) in the treatment of pulmonary tuberculosis.

R L YEAGER, W G C MUNROE, F I DESSAU.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID/derivatives; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1952        PMID： 13038888

Source DB:  PubMed          Journal:  Trans Annu Meet Natl Tuberc Assoc        ISSN： 0096-6290


× No keyword cloud information.
  3 in total

Review 1.  Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide.

Authors:  Pooja Gopal; Gerhard Grüber; Véronique Dartois; Thomas Dick
Journal:  Trends Pharmacol Sci       Date:  2019-11-06       Impact factor: 14.819

2.  The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells.

Authors:  Susana Mendez; Ryan Traslavina; Meleana Hinchman; Lu Huang; Patricia Green; Michael H Cynamon; John T Welch
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

Review 3.  The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors.

Authors:  Kyle H Rohde; Leonardo Sorci
Journal:  Front Microbiol       Date:  2021-01-26       Impact factor: 5.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.